凶兆 发表于 2025-4-1 04:40:48
http://reply.papertrans.cn/59/5833/583298/583298_61.png飞镖 发表于 2025-4-1 07:10:54
Michael Neise,Susanne Zankwas gemtuzumab ozogamicin (Mylotarg), which targeted CD33 on the surface of acute myeloid leukaemia cells and delivered the potent cytotoxic agent, calicheamicin, inside the leukaemia cells. In 2010, gemtuzumab ozogamicin was withdrawn from the market after failing to produce sufficient efficacy in纵欲 发表于 2025-4-1 14:09:31
http://reply.papertrans.cn/59/5833/583298/583298_63.png